As the largest retail pharmacy chain in the country, Walgreen's (WAG) 7,800 stores reach more Americans than those of its rivals. At the same time, the firm is poised to benefit from one of the biggest trends in the pharmaceutical industry right now: the barrage of patent drop-offs that's threatening drugmakers' revenues for the next few years.
Combined, those factors should help Walgreen shake off the economic headwinds that are blowing its way.Scale is Walgreen's biggest advantage. Coupled with the patent drop-off issue (which should drive higher margins through the sale of generics), size could mean higher levels of profitability than peers. But what Walgreen's peers lack in scale, they make up for in ingenuity. Rivals such as CVS Caremark (CVS) have added pharmacy benefits management to their repertoires to take a share of pharmacy sales on two fronts. Walgreen will need to keep up with new offers (such as in-store clinics) if it wants to continue its performance. On the growth front, one major positive is saturation -- or rather the lack thereof. Despite Walgreen's huge geographic footprint, the company still hasn't reached saturation in the U.S., and it should be able to offer growth to investors for years to come. That's helped by a healthy balance sheet position with ample room to spend cash on growing a capital base. With analyst sentiment on the rise this week, we're betting on shares ahead of Wednesday's earnings call. Walgreen, one of the highest-yielding retail stocks, shows up on a recent list of 10 Stocks Gloomy Goldman Sachs Is Bullish On.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV